siRNA treatment lowers triglycerides in individuals along with rare ailment
.RESEARCH STUDY FEATURE.19 September 2024.
Plozasiran lowered triglyceride degrees by 80% as well as reduced the danger of pancreatitis in clients along with constant chylomicronemia, with or without a hereditary diagnosis.